Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia

L. A. Ruiz, M. Alfonso, A. Gomez, S. Pedrero, N. Marina, M. Inchausti, I. Seijas, C. Jaca, R. Zalacain (Barakaldo, Spain)

Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Session: Assessment of severity and predictors of outcomes in community-acquired pneumonia
Session type: Thematic Poster Session
Number: 2484
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. A. Ruiz, M. Alfonso, A. Gomez, S. Pedrero, N. Marina, M. Inchausti, I. Seijas, C. Jaca, R. Zalacain (Barakaldo, Spain). Role of pneumococcus urinary antigen testing in the clinical presentation and outcome of pneumococcal bacteraemic community acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 2484

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Usefulness of urinary pneumococcal antigen testing in patients with community acquired pneumonia
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009

Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003


Clinical features of patients with pneumococcal urinary antigen positivity, in a cohort of hospitalised community acquired pneumonia
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Impact of determination of urine pneumococcal antigen in the diagnosis of community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008


Sputum and streptococcus pneumoniae urinary antigen test for diagnosis of pneumococcal community acquired pneumonia
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003



Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017


The relationship between the result of urinary antigen detection kit for Streptococcus pneumoniae and clinical effect of treatment in patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 412s
Year: 2004

Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals
Source: ERJ Open Res, 2 (4) 00011-2016; 10.1183/23120541.00011-2016
Year: 2016



Urinary antigen testing for pneumococcal pneumonia: is there evidence to make its use uncommon in clinical practice?
Source: ERJ Open Res, 6 (1) 00223-2019; 10.1183/23120541.00223-2019
Year: 2020



Performance of the binax NOW Streptococcus pneumoniae urinary antigen assay among children with underlying pulmonary diseases in the absence of acute pneumococcal infection
Source: Eur Respir J 2004; 24: Suppl. 48, 391s
Year: 2004

Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006



Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007



The risk factors of clinical practice for bacteremia in community- acquired pneumococcal pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Lymphopenic community acquired pneumococcal pneumonia: Clinical characteristics and outcome
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016



Streptococcus pneumoniae resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013